RNA AVIDITY BIOSCIENCES INC

Ownership history in NWAM LLC  ·  19 quarters on record

This page tracks every 13F SEC filing in which NWAM LLC reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.29% (2024 Q2)
Avg. % of fund
0.05%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 10,824 -2,773 -20.4% 0.04% $507K
2025 Q2 REDUCED 13,597 -1,809 -11.7% 0.04% $501K
2025 Q1 ADDED 15,406 +309 +2.0% 0.04% $455K
2024 Q4 REDUCED 15,097 -14,565 -49.1% 0.03% $439K
2024 Q3 ADDED 29,662 +5,746 +24.0% 0.08% $1.4M
2024 Q2 REDUCED 23,916 -3,446 -12.6% 0.29% $977K
2024 Q1 REDUCED 27,362 -1,959 -6.7% 0.06% $695K
2023 Q4 REDUCED 29,321 -6,372 -17.9% 0.02% $265K
2023 Q3 ADDED 35,693 +4,928 +16.0% 0.02% $228K
2023 Q2 ADDED 30,765 +9,265 +43.1% 0.03% $341K
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    RNA price (monthly, adj. close)
← Back to NWAM LLC Holdings